王敏



【摘 要】 目的:研究克林霉素和保妇康栓治疗慢性宫颈炎伴高危型人乳头瘤病毒感染的临床疗效。方法:选本院就诊的150例慢性宫颈炎患者,分为两组各75例。对照组保妇康栓治疗,研究组保妇康栓和克林霉素,比较两组治疗效果。结果:研究组有效率较对照组高,不良反应发生率较对照组低,P<0.05;研究组CRP、IL-6及TNF-α水平较对照组明显升高,P<0.05。结论:对慢性宫颈炎病患同时应用克林霉素和保妇康栓干预,疗效佳,不良反应少,且能够缓解炎性状态。
【关键词】 克林霉素;保妇康栓;慢性宫颈炎;人乳头瘤病毒
文章编号:WHR201910121
[Abstract] Objective:To study the clinical efficacy of clindamycin and Baofukang suppository in the treatment of chronic cervicitis with high-risk human papillomavirus infection.Methods: A total of 150 patients with chronic cervicitis who were admitted to our hospital were divided into two groups of 75 patients. In the control group, Baofukang suppository was treated, and the experimental group was treated with Baofukang suppository and clindamycin. The therapeutic effects of the two groups were compared.Results: The effective rate of the experimental group was higher than that of the control group. The incidence of adverse reactions was lower than that of the control group, P<0.05. The levels of CRP, IL-6 and TNF-α in the experimental group were significantly higher than those in the control group,P<0.05. Conclusion: The combination of clindamycin and Baofukang suppository in patients with chronic cervicitis has good curative effect, less adverse reactions, and can alleviate the inflammatory state.
[Key words]Clindamycin; Baofukang suppository; Chronic cervicitis; Human papillomavirus
慢性宮颈炎为妇科常见疾病,该病的发病率以及疾病的复发率均较高。慢性宫颈炎常同时伴有人乳头瘤病毒(HPV)的感染,感染率一般高达36%~60%[1]。慢性宫颈炎病患若是伴有人HPV感染,会增加出现宫颈癌的概率,给病患家庭以及整个社会带来极大的负担,所以需要给慢性宫颈炎患者提供及时有效的干预,通过该方式可以有效地降低发生宫颈癌的概率[2]。为进一步的探究克林霉素联合保妇康栓如何影响慢性宫颈炎患者的疗效,现本院将选2018年8月至2019年8月来本院就诊的150例慢性宫颈炎患者作为研究对象开展深入探究,详细研究结果见下:
1 资料及方法
1.1 一般资料
经过医院伦理委员会审批,选2018年8月至2019年8月来本院就诊的150例慢性宫颈炎病患入选本次研究,年龄区间为31~62(45.34±9.22)岁,患者按照1∶1等分,共分为两组。研究组病患年龄区间是:41~72(44.43±12.14)岁,平均病程是(17.35±4.21)月,其中40例表现为白带增多,35例为阴道异常出血;40例为轻度宫颈糜烂,21例为中度宫颈糜烂,14例为重度宫颈糜烂;对照组病患的年龄区间为44~69(46.68±14.33)岁,平均病程是(15.35±4.42)月;其中36例……